145 related articles for article (PubMed ID: 37202742)
1. LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma.
Chen Y; Ma F; Zhang Z; Guo Y; Shen H; Chen H
BMC Cancer; 2023 May; 23(1):455. PubMed ID: 37202742
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of long noncoding RNA PVT1 attenuates paclitaxel resistance in glioma cells.
Song T; Yan L; Cai K; Zhao T; Xu M
Cancer Biomark; 2018; 23(3):447-453. PubMed ID: 30347597
[TBL] [Abstract][Full Text] [Related]
3. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-XIST interacts with
Du P; Zhao H; Peng R; Liu Q; Yuan J; Peng G; Liao Y
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28831025
[TBL] [Abstract][Full Text] [Related]
5. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA PVT1 Inhibits Glioma Progression by Regulating miR-424 Expression.
Han Y; Li X; He F; Yan J; Ma C; Zheng X; Zhang J; Zhang D; Meng C; Zhang Z; Ji X
Oncol Res; 2019 Jun; 27(6):681-690. PubMed ID: 30832754
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway.
Wang P; Peng X; Zhang J; Wang Z; Meng J; Cen B; Ji A; He S
Apoptosis; 2018 Dec; 23(11-12):651-666. PubMed ID: 30232656
[TBL] [Abstract][Full Text] [Related]
8. LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways.
Cheng M; Wang Q; Chen L; Zhao D; Tang J; Xu J; He Z
Hum Pathol; 2022 May; 123():59-73. PubMed ID: 35219686
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761.
Wang W; Han S; Gao W; Feng Y; Li K; Wu D
Cell Mol Neurobiol; 2022 Apr; 42(3):695-708. PubMed ID: 32897512
[TBL] [Abstract][Full Text] [Related]
10. Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
Hong X; Zhang J; Zou J; Ouyang J; Xiao B; Wang P; Peng X
Cell Signal; 2023 Feb; 102():110560. PubMed ID: 36521657
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
Liao Y; Shen L; Zhao H; Liu Q; Fu J; Guo Y; Peng R; Cheng L
J Cell Biochem; 2017 Jul; 118(7):1889-1899. PubMed ID: 28121023
[TBL] [Abstract][Full Text] [Related]
12. LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma.
Chen WL; Chen HJ; Hou GQ; Zhang XH; Ge JW
Aging (Albany NY); 2019 Aug; 11(16):6053-6068. PubMed ID: 31469661
[TBL] [Abstract][Full Text] [Related]
13. ZNF300 enhances temozolomide resistance in gliomas by regulating lncRNA SNHG12.
Fu J; Peng J; Tu G
Gen Physiol Biophys; 2022 Jul; 41(4):349-355. PubMed ID: 35938968
[TBL] [Abstract][Full Text] [Related]
14. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
[TBL] [Abstract][Full Text] [Related]
15. lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2-mediated PI3K/AKT pathway in glioma.
Zhou J; Xu N; Liu B; Wang C; He Z; Lenahan C; Tang W; Zeng H; Guo H
Cancer Sci; 2022 Aug; 113(8):2681-2692. PubMed ID: 35637600
[TBL] [Abstract][Full Text] [Related]
16. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
Sun ZY; Jian YK; Zhu HY; Li B
Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
[TBL] [Abstract][Full Text] [Related]
17. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.
Han B; Meng X; Wu P; Li Z; Li S; Zhang Y; Zha C; Ye Q; Jiang C; Cai J; Jiang T
Theranostics; 2020; 10(7):3351-3365. PubMed ID: 32194873
[No Abstract] [Full Text] [Related]
18. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
19. Identification of a three-long non-coding RNA signature for predicting survival of temozolomide-treated isocitrate dehydrogenase mutant low-grade gliomas.
Li R; Chen W; Mao P; Wang J; Jing J; Sun Q; Wang M; Yu X
Exp Biol Med (Maywood); 2021 Jan; 246(2):187-196. PubMed ID: 33028081
[TBL] [Abstract][Full Text] [Related]
20. Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review).
Li S; Xie X; Peng F; Du J; Peng C
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35796022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]